Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Track ALVO with free AI briefings, catalyst countdowns, and dilution alerts.

ALVO · Alvotech

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

Follow ALVO by email Get an email when ALVO pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about ALVO, unsubscribe in one click. Privacy

📣 What ALVO Says Is Next

during 2026 · “Alvotech continues to expect FDA approval for the relevant BLAs during 2026.”
Company press release, May 11, 2026 · SEC filing
late 2026 · “Alvotech anticipates receiving U.S. approval by late 2026 for four Biologics License Applications from the U.S. Food and Drug Administration, with minimal impact on the topline.”
Company press release, Mar 19, 2026 · SEC filing

Quoted word for word from the company's press releases filed with the SEC. Timing is the company's own guidance, not a BioRadar estimate.

💰 Cash Runway & Dilution Risk

Dilution pressure: 25 · Moderate

Cash runway not available
ATM program on file since Jun 2026 +15
Shelf registration (F-3, Oct 2023) +10

Recent financing filings on SEC EDGAR:

Jun 16, 2026 · ATM program · 424B5
Jun 15, 2026 · ATM program · 424B5
Jun 14, 2024 · ATM program, up to $75M · 424B5
Oct 20, 2023 · Shelf registration, up to $100M · F-3

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when ALVO files for a raise →

👥 Who Owns ALVO

Insiders Form 4 data not loaded yet Other 5%+ holders 67.7% Institutions (104 holders) 12.8% Public and other holders 19.5%

Holder	Type	Shares	% of shares	As of
Celtic Holdings S.C.A.	5%+ holder (13D)	107,450,988	34.44%	2026-06-26
Aztiq Pharma Partners S.a r.l.	5%+ holder (13D)	103,849,420	33.28%	2025-12-17

Share count 312,021,375 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full ALVO picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for ALVO and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z